Webinar Details
Title: Genzyme’s Next Generation Pompe Treatment: Clinical Development Overview
Date: Thursday, February 3, 2011
Speakers:
Edward Kaye, MD
Alison McVie-Wylie, PhD
Speaker Biographies:
Dr. Kaye is currently Group V.P. and Therapeutic Area Head in Clinical Research at Genzyme Corporation where he supervises the clinical research in the lysosomal storage disease programs and in the genetic neurological disorders.
Dr. McVie-Wylie is the Scientific Director of the Pharmacology and Toxicology group at Genzyme Corporation. Alison manages a group of scientists who design, execute, interpret and report studies to support preclinical drug development of novel biologic therapeutics. Alison was the lead Scientist responsible for the preclinical development and licensure of Myozyme.